View in EDS

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.

Saved in:
Bibliographic Details
Title: Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
Authors: Juan-Giner A; Epicentre, Paris, France., Namulwana ML; Epicentre Mbarara Research Centre, Mbarara, Uganda., Kimathi D; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Grantz KH; Department of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Fall G; Institut Pasteur Dakar, Dakar, Senegal., Dia M; Institut Pasteur Dakar, Dakar, Senegal., Bob NS; Institut Pasteur Dakar, Dakar, Senegal., Sall AA; Institut Pasteur Dakar, Dakar, Senegal., Nerima C; Epicentre Mbarara Research Centre, Mbarara, Uganda., Sahani MK; Epicentre Mbarara Research Centre, Mbarara, Uganda., Mulogo EM; Department of Community Health, Mbarara University of Science & Technology, Mbarara, Uganda., Ampeire I; Expanded Program on Immunization, Ministry of Health, Kampala, Uganda., Hombach J; Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland., Nanjebe D; Epicentre Mbarara Research Centre, Mbarara, Uganda., Mwanga-Amumpaire J; Epicentre Mbarara Research Centre, Mbarara, Uganda., Cummings DAT; Department of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA., Bejon P; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Warimwe GM; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK., Grais RF; Epicentre, Paris, France. Electronic address: rebecca.grais@epicentre.msf.org.
Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Aug; Vol. 23 (8), pp. 965-973. Date of Electronic Publication: 2023 Apr 28.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't; Equivalence Trial
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37127047
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Juan-Giner+A%22">Juan-Giner A</searchLink>; Epicentre, Paris, France.<br /><searchLink fieldCode="AU" term="%22Namulwana+ML%22">Namulwana ML</searchLink>; Epicentre Mbarara Research Centre, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Kimathi+D%22">Kimathi D</searchLink>; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Grantz+KH%22">Grantz KH</searchLink>; Department of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fall+G%22">Fall G</searchLink>; Institut Pasteur Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Dia+M%22">Dia M</searchLink>; Institut Pasteur Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Bob+NS%22">Bob NS</searchLink>; Institut Pasteur Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Sall+AA%22">Sall AA</searchLink>; Institut Pasteur Dakar, Dakar, Senegal.<br /><searchLink fieldCode="AU" term="%22Nerima+C%22">Nerima C</searchLink>; Epicentre Mbarara Research Centre, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Sahani+MK%22">Sahani MK</searchLink>; Epicentre Mbarara Research Centre, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Mulogo+EM%22">Mulogo EM</searchLink>; Department of Community Health, Mbarara University of Science & Technology, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Ampeire+I%22">Ampeire I</searchLink>; Expanded Program on Immunization, Ministry of Health, Kampala, Uganda.<br /><searchLink fieldCode="AU" term="%22Hombach+J%22">Hombach J</searchLink>; Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Nanjebe+D%22">Nanjebe D</searchLink>; Epicentre Mbarara Research Centre, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Mwanga-Amumpaire+J%22">Mwanga-Amumpaire J</searchLink>; Epicentre Mbarara Research Centre, Mbarara, Uganda.<br /><searchLink fieldCode="AU" term="%22Cummings+DAT%22">Cummings DAT</searchLink>; Department of Biology and Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Bejon+P%22">Bejon P</searchLink>; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Warimwe+GM%22">Warimwe GM</searchLink>; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya; Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Grais+RF%22">Grais RF</searchLink>; Epicentre, Paris, France. Electronic address: rebecca.grais@epicentre.msf.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101130150%22">The Lancet. Infectious diseases</searchLink> [Lancet Infect Dis] 2023 Aug; Vol. 23 (8), pp. 965-973. <i>Date of Electronic Publication: </i>2023 Apr 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't; Equivalence Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101130150 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-4457 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214733099%22">14733099 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37127047
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S1473-3099(23)00131-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 965
    Titles:
      – TitleFull: Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Juan-Giner A
      – PersonEntity:
          Name:
            NameFull: Namulwana ML
      – PersonEntity:
          Name:
            NameFull: Kimathi D
      – PersonEntity:
          Name:
            NameFull: Grantz KH
      – PersonEntity:
          Name:
            NameFull: Fall G
      – PersonEntity:
          Name:
            NameFull: Dia M
      – PersonEntity:
          Name:
            NameFull: Bob NS
      – PersonEntity:
          Name:
            NameFull: Sall AA
      – PersonEntity:
          Name:
            NameFull: Nerima C
      – PersonEntity:
          Name:
            NameFull: Sahani MK
      – PersonEntity:
          Name:
            NameFull: Mulogo EM
      – PersonEntity:
          Name:
            NameFull: Ampeire I
      – PersonEntity:
          Name:
            NameFull: Hombach J
      – PersonEntity:
          Name:
            NameFull: Nanjebe D
      – PersonEntity:
          Name:
            NameFull: Mwanga-Amumpaire J
      – PersonEntity:
          Name:
            NameFull: Cummings DAT
      – PersonEntity:
          Name:
            NameFull: Bejon P
      – PersonEntity:
          Name:
            NameFull: Warimwe GM
      – PersonEntity:
          Name:
            NameFull: Grais RF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2023 Aug
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1474-4457
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: The Lancet. Infectious diseases
              Type: main
ResultId 1